Ultra Brahmi | Promoting mental clarity & concentration | Backed by clinical research

About the herb:

Brahmi (Bacopa monnieri) has been traditionally used by yogis and practitioners of Ayurvedic medicine for its potential cognitive and mental benefits. In Ayurveda, Brahmi is considered a powerful herb for promoting mental clarity, concentration, and enhancing spiritual awareness.

It contains active compounds, such as bacosides, which are believed to enhance brain function and positively impact the nervous system, helping to promote a sense of calmness and relaxation. As a result, it is often used as a natural nootropic or brain-boosting supplement.

Why is this Brahmi special?

There are many varieties of Brahmi, and different extraction processes can cause significant variations in quality.

To find the most potent Brahmi, the team at Amulya Research Center tested all forms of traditional Brahmi extracts but found them lacking in efficacy.

The expert team of doctors at Amulya Research Center created a proprietary method of growing, cultivating, and processing Bacopa monnieri (Brahmi) into Ultra Brahmi Capsules, which retain the highest concentration of Bacosides and other lesser-known active compounds.

--------

The Science:

Active compounds in Brahmi
Brahmi (Bacopa) contains bacosides A & B, sterols, alkaloids, and polyphenols.
Bacoside A and B are the major constituents found in the Bacopa monnieri (Brahmi) plant, present as saponins.
Other active compounds include hersaponin, apigenin, D-mannitol, monnierasides I-III, plantainoside B, cucurbitacin, and alkaloids such as brahmine, herpestine, and nicotine.

Benefits of Brahmi according to clinical research:

• Improves memory & prevents memory loss
  In a double-blind, randomized, placebo-controlled trial of 35 subjects aged above 55 years using the Wechsler Memory Scale, significant improvement in total memory score was observed after 8 weeks of administering Bacopa monnieri (Brahmi).

• Helpful for ADHD patients
  In a double-blind, randomized, placebo-controlled trial of 36 children with Attention Deficit Hyperactivity Disorder (ADHD), restlessness symptoms were reduced in 93% of children taking Bacopa monnieri (Brahmi). Improvement in self-control was observed in 89%, and attention-deficit symptoms were reduced in 85% of the children.

• Aids in treating Alzheimer’s and schizophrenia
  Cognitive deficits in rats induced by PCP were mitigated by Bacopa monnieri (Brahmi). Administering Brahmi before PCP exposure restored cognitive function by decreasing NMDAR1 in affected brain areas, suggesting Brahmi may be a novel neuroprotective agent for preventing cognitive deficits in schizophrenia and Alzheimer’s disease.

• Powerful antioxidant & anti-inflammatory agent
  A study on rat brains showed that Bacopa monnieri (Brahmi) has significant antioxidant effects after sub-chronic administration, extending to the hippocampus. This increased oxidative free radical scavenging activity may explain Brahmi’s cognition-enhancing properties.

• Helps reduce seizures
  In a study by E. Komali, rats induced with seizures were treated with Bacopa monnieri (Brahmi) as an anti-epileptic treatment. Results showed that selected Brahmi extracts offered neuroprotection by restoring cholinergic activity during induced epilepsy.

• Enhances retention of new information
  Bacopa monnieri (Brahmi) has been shown to enhance learning capacity. A 3-month study involving 76 subjects aged 40–65 at the University of Wollongong, Australia, demonstrated significant effects on the retention of new information.

• Reduces cortisol levels
  In a study by Micheli, Bacopa monnieri (Brahmi) significantly reduced cortisol, cytokines, and LPS-dependent alterations in plasma, while increasing brain-derived neurotrophic factor levels.